R-268712 is a research compound that functions as an inhibitor of anaplastic lymphoma kinase (ALK). It is a pyrazole-containing heterocyclic compound with a terminal alcohol group, designed for laboratory studies in ALK-related signaling pathways.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 879487-87-3
(²H₄)Benzene-1,2-dicarboxylic acid
research compound
N-Succinimidyl 11-(maleimido)undecanoate
research compound
2-iodobenzoic acid
research compound
2-Aminobenzamide
research compound
2-[4-[2-fluoro-5-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]phenyl]pyrazol-1-yl]ethanol
JQGOCCALXFSRHZ-UHFFFAOYSA-N
CC1=NC(=CC=C1)C2=C(C=NN2)C3=CC(=C(C=C3)F)C4=CN(N=C4)CCO